Google Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively.
In 2020, the company made a significant advance in molecular biology by using AI to successfully predict the behaviour of microscopic proteins.
With the latest incarnation of AlphaFold, researchers at DeepMind and sister company Isomorphic Labs—both overseen by cofounder Demis Hassabis—have mapped the behaviour for all of life’s molecules, including human DNA.
The interactions of proteins—from enzymes crucial to the human metabolism, to the antibodies that fight infectious diseases—with other molecules is key to drug discovery and development.
DeepMind said the findings, published in research journal Nature on Wednesday, would reduce the time and money needed to develop potentially life-changing treatments.
“With these new capabilities, we can design a molecule that will bind to a specific place on a protein, and we can predict how strongly it will bind,” Hassabis said in a press briefing on Tuesday.
“It’s a critical step if you want to design drugs and compounds that will help with disease.”
The company also announced the release of the “AlphaFold server”, a free online tool that scientists can use to test their hypotheses before running real-world tests.
Since 2021, AlphaFold’s predictions have been freely accessible to non-commercial researchers, as part of a database containing more than 200 million protein structures, and has been cited thousands of times in others’ work.
DeepMind said the new server required less computing knowledge, allowing researchers to run tests with just a few clicks of a button.
John Jumper, a senior research scientist at DeepMind, said: “It’s going to be really important how much easier the AlphaFold server makes it for biologists—who are experts in biology, not computer science—to test larger, more complex cases.”
Dr Nicole Wheeler, an expert in microbiology at the University of Birmingham, said AlphaFold 3 could significantly speed up the drug discovery pipeline, as “physically producing and testing biological designs is a big bottleneck in biotechnology at the moment”.
—Martin Coulter, Reuters
Jelentkezéshez jelentkezzen be
EGYÉB POSTS Ebben a csoportban
The way Bran Ferren sees it, the future of warfare depends as much on creativity as it does on raw firepower.
The former head of research and development at Walt Disney Imagineering—the
The nonstop cavalcade of announcements in the AI world has created a kind of reality distortion field. There is so much bu
Google released its new Gemini 2.5 Pro Experimental AI model late last month,
TikTok is shutting down TikTok Notes—wait, you didn’t even know it existed? Well, that explains a lot.
TikTok Notes, the platform’s short-lived attempt to take on Instagram (just as Inst
Influencing has a major pay gap, and it’s not what you might expect.
A new report from Collabstr, based on over 15,0
Tech leaders often brand themselves as “disruptors”—and few fit that label more snugly than Elon Musk. In the three months since joining Donald Trump in the White House following Trump’s election,
